↓ Skip to main content

A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis

Overview of attention for article published in BMC Infectious Diseases, August 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
10 tweeters

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
103 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis
Published in
BMC Infectious Diseases, August 2016
DOI 10.1186/s12879-016-1727-4
Pubmed ID
Authors

Mahshid Aryanpur, Mostafa Hosseini, Mohammad Reza Masjedi, Esmaeil Mortaz, Payam Tabarsi, Hamid Soori, Habib Emami, Gholamreza Heidari, Mehdi Kazempour Dizagie, Masoud Baikpour

Abstract

Tuberculosis (TB) and tobacco use are two major alarming global health issues that tend to be co-prevalent in many developing countries and various surveys have provided evidence on their entangled associations. Accordingly, it is strongly suggested that smoking cessation be incorporated in TB control programs. Therefore, we aimed to evaluate the effectiveness of two smoking cessation methods among newly-diagnosed pulmonary TB patients. A total of 210 newly-diagnosed pulmonary TB patients from Tehran, Iran with smoking habits were included in this randomized clinical trial during 2012-2013. Patients were assigned to three groups of control (just TB medical treatment), brief advice (TB medical treatment plus individualized counseling sessions of quitting behavioral therapy) and combined intervention (TB medical treatment plus individualized counseling sessions of quitting behavioral therapy plus medical treatment with slow release bupropion). Patients' abstinence was followed at six time point during six months. Data were analyzed by SPSS v.22 using Generalized Estimating Equations (GEE) model. Abstinance rate at the end of six months were 71.7 % for combined intervention group, 33.9 % for brief advice group and 9.8 % for the control group (p < 0.001). Combined intervention group and brief advice group respectively had 35 times (p < 0.001, OR = 35.26, 95 % CI = 13.77-90.32) and 7 times (p < 0.001, OR = 7.14, 95 % CI = 2.72-18.72) more odds of not being an active smoker at each time point, compared to the control group. Considering the prevalence and importance of TB and the substantial influence of these preventive measures on controlling tobacco use, application of such programs is recommended. The survey was registered in the Iranian registry of clinical trials website (irct.ir) in August 31, 2013 with IRCT ID: IRCT2013062613783N1 .

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 103 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 17%
Researcher 17 17%
Student > Bachelor 11 11%
Student > Postgraduate 6 6%
Professor > Associate Professor 5 5%
Other 21 20%
Unknown 26 25%
Readers by discipline Count As %
Medicine and Dentistry 39 38%
Nursing and Health Professions 10 10%
Psychology 6 6%
Biochemistry, Genetics and Molecular Biology 4 4%
Immunology and Microbiology 3 3%
Other 11 11%
Unknown 30 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2017.
All research outputs
#1,817,793
of 12,184,320 outputs
Outputs from BMC Infectious Diseases
#586
of 4,484 outputs
Outputs of similar age
#55,813
of 252,518 outputs
Outputs of similar age from BMC Infectious Diseases
#36
of 210 outputs
Altmetric has tracked 12,184,320 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,484 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 252,518 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 210 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.